Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jonathan Jagid

Neurological Surgery Miami, FL Medical Doctor

NPI 1699792119 CMS profile 212495

1475 Nw 12Th Ave., Miami, FL 33136

Open in the dashboard

General payments

$34,284

84 records reported · program years 2019–2025

Research payments

$1,320

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$730,768 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Jonathan Jagid of Miami, FL is reported in the CMS Open Payments database as having received $34,284 across 84 general payments and $1,320 in research payments paid to them. Separately, studies naming them as principal investigator received $730,768 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 83rd percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $308 5
2024 General $346 6
2023 General $5,871 15
2022 General $10,300 16
2021 General $6,453 15
2020 General $4,037 6
2020 Research $1,320 1
2019 General $6,968 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jonathan Jagid
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Jonathan Jagid were reported at $308. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Jonathan Jagid Neurological Surgery median Middle half National median
2019 $6,968 $582 $138–$3,006 $163
2020 $4,037 $294 $76–$2,174 $114
2021 $6,453 $387 $105–$2,432 $132
2022 $10,300 $542 $139–$2,989 $149
2023 $5,871 $534 $145–$2,697 $160
2024 $346 $574 $155–$3,046 $164
2025 $308 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $13,901 27 payments
  2. Boston Scientific Corporation $10,952 22 payments
  3. Medtronic USA, Inc. $6,057 18 payments
  4. Medtronic, Inc. $2,785 9 payments
  5. InSightec,Inc $163 2 payments
  6. Integra LifeSciences Corporation $155 1 payment
  7. Zimmer Biomet Holdings, Inc. $125 2 payments
  8. Natus Medical Incorporated $104 1 payment
  9. DePuy Synthes Sales Inc. $40 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $19,841 16 payments
  2. Compensation for serving as faculty or as a speaker for a medical education program $11,900 20 payments
  3. Food and Beverage $2,343 47 payments
  4. Education $200 1 payment
Products named General payments · program years 2019–2025
  1. INFINITY $8,875 14 payments
  2. GENERAL DBS Dbs $3,500 1 payment
  3. VISUALASE $3,200 4 payments
  4. General - DBS General - DBS_NMD $3,105 5 payments
  5. ACTIVA $2,842 13 payments
  6. PERCEPT PC BRAINSENSE $2,566 2 payments
  7. Proclaim DRG IPG $2,500 4 payments
  8. IonicRF Generator $2,250 5 payments
  9. GENERAL DBS Pain Management $1,347 2 payments
  10. GENERAL - DBS Dbs $1,000 2 payments
  11. Other $1,369 26 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic USA, Inc. $1,320 1 payment

Billing to Medicare

Part B · data year 2024 · 20 billing codes

Paid by Medicare

$69,871

Medicare's payments for the services billed

Medicare patients

55

Average age 71

Services billed

133

12 women, 43 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 69%
Arthritis 44%
Depression 42%
Diabetes 35%
Ischemic heart disease 33%
Alzheimer's or dementia 27%
Atrial fibrillation 24%
Chronic kidney disease 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

85 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record